Franck Rodet
Lille, 59000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome.
Journal: Cell death & disease
Published: October 13, 2023
Heimdall, an alternative protein issued from a ncRNA related to kappa light chain variable region of immunoglobulins from astrocytes: a new player in neural proteome.
Journal: Cell death & disease
Published: January 04, 2023
The Antibody Dependant Neurite Outgrowth Modulation Response Involvement in Spinal Cord Injury.
Journal: Frontiers in immunology
Published: February 24, 2022
The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response.
Journal: Frontiers in immunology
Published: February 14, 2021
Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages.
Journal: Cancer gene therapy
Published: September 09, 2020
The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth.
Journal: Molecular therapy oncolytics
Published: February 06, 2020
PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype.
Journal: Cells
Published: October 23, 2019
3D MALDI mass spectrometry imaging reveals specific localization of long-chain acylcarnitines within a 10-day time window of spinal cord injury.
Journal: Scientific reports
Published: June 07, 2018
Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy.
Journal: Journal of biotechnology
Published: April 19, 2018
Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.
Journal: Molecular & cellular proteomics : MCP
Published: November 01, 2017
Proprotein convertase 1/3 inhibited macrophages: A novel therapeutic based on drone macrophages.
Journal: EuPA open proteomics
Published: October 24, 2015
Last Updated: 09/26/2026